SCHEMBL10457151

SCHEMBL10457151

CCCC(=O)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SIRT2 Q8IXJ6 14/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRE P78334 1/20 0.39
GABRA6 Q16445 1/20 0.39
GABRG1 Q8N1C3 1/20 0.39
GABRG3 Q99928 1/20 0.39
GABRQ Q9UN88 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9518341 0.92 FLT3 (0.38) SIRT2FLT3TYRO3MERTKGAS6
SCHEMBL1414901 0.89 SIRT2 (0.40) SMN1; SMN2L3MBTL1SIRT2CYP11B1CYP11B2
SCHEMBL1735234 0.87 CYP11B1 (0.37) SIRT2CYP11B1CYP11B2NMBR
SCHEMBL1736018 0.85 SIRT2 (0.36) L3MBTL1SIRT2CYP11B1CYP11B2
SCHEMBL8865971 0.85 KCNH2 (0.42) SIRT2CES1
SCHEMBL9489847 0.83 SIRT2 (0.40) SIRT2CYP11B1CYP11B2NMBR
SCHEMBL4030251 0.82 SIRT2 (0.40) SIRT2CYP11B1CYP11B2NMBR
SCHEMBL1483017 0.82 SIRT2 (0.39) L3MBTL1SIRT2CYP11B1CYP11B2CES2
SCHEMBL1040045 0.81 CYP11B1 (0.41) SIRT2CYP11B1CYP11B2
SCHEMBL9789313 0.81 SIRT2 (0.42) SMN1; SMN2SIRT2GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0194984-B1 DERIVATIVES OF IMIDAZOLE, THEIR PREPARATION AND UTILISATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES CONTINENTAL PHARMA, INC. (BE) 1990-04-04 EP disclosed
US-4738979-A ADRENERGIC RECEPTORS; ANTI-CONVULSIVE DRUG; TREATMENT OF METABOLIC AND NEUTRAL DISORDERS G. D. SEARLE & CO. (US) 1988-04-19 US disclosed